Melatonin: Potential avenue for treating iron overload disorders

Ageing Res Rev. 2022 Nov:81:101717. doi: 10.1016/j.arr.2022.101717. Epub 2022 Aug 10.

Abstract

Iron overload as a highly risk factor, can be found in almost all human chronic and common diseases. Iron chelators are often used to treat iron overload; however, patient adherence to these chelators is poor due to obvious side effects and other disadvantages. Numerous studies have shown that melatonin has a high iron chelation ability and direct free radical scavenging activity, and can inhibit the lipid peroxidation process caused by iron overload. Therefore, melatonin may become potential complementary therapy for iron overload-related disorders due to its iron chelating and antioxidant activities. Here, the research progress of iron overload is reviewed and the therapeutic potential of melatonin in the treatment of iron overload is analyzed. In addition, studies related to the protective effects of melatonin on oxidative damage induced by iron overload are discussed. This review provides a foundation for preventing and treating iron homeostasis disorders with melatonin.

Keywords: Antioxidant; Iron chelating; Iron metabolism; Iron overload; Melatonin; Neurodegenerative diseases; Reactive oxygen species.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antioxidants / pharmacology
  • Antioxidants / therapeutic use
  • Free Radicals
  • Humans
  • Iron / therapeutic use
  • Iron Chelating Agents / pharmacology
  • Iron Chelating Agents / therapeutic use
  • Iron Overload* / drug therapy
  • Melatonin* / pharmacology
  • Melatonin* / therapeutic use

Substances

  • Antioxidants
  • Free Radicals
  • Iron Chelating Agents
  • Iron
  • Melatonin